Epidemiology of Hepatocellular Carcinoma in Fayoum Governorate-EgyptEpidemiology of Hepatocellular Carcinoma in Fayoum Governorate-Egypt

Authors

  • Naglaa A. El Sherbiny Public Health Dept Fayoum University
  • Samy Zaky Tropical Medicine Dept2.-El-Azhar University
  • Ahmed A. Gomma Tropical Medicine Dept3. Fayoum University-Egypt
  • Essam A. Hassan (N. A. El-Sherbiny)
  • Nancy A. Atta (N. A. El-Sherbiny)

Keywords:

Hepatocellular carcinoma, epidemiology, HCV, Fayoum.

Abstract

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and the burden is expected to increase in coming years. HCC has become the second most prevalent cancer among men in Egypt. This study aimed to estimate the prevalence; identify the risk factors and detect clinical features of HCC in Fayoum governorate. The study was a descriptive cross-sectional study with a convenient sample conducted at Tropical & Hepatology Medicine Department in Fayoum University Teaching Hospital. An interview structured questionnaire was used; thorough clinical examination with biochemical and serological investigation. The majority of cases came from rural area, farmers constituted 39.3% of cases. More than 90% of cases suffering from hepatic cirrhosis and more than half of cases having Bilhariziasis. Hepatitis C was the main aetiology 79.8%, followed by hepatitis B 15.4%.

Most of focal lesions were in right lobe 57.1% and in the form of single lesion 57.1%. AFP was found to be a weak diagnostic predictor with low sensitivity. HCC was multifactorial pathogenesis with many risk factors (cirrhosis, HCV and schistosomiasis). HBV infection has a declining role in hepatocarcinogenesis. Proper surveillance program is needed for early detection and diagnosis of HCC

References

. R. Aravalli, and Steer (2012) Cellular and molecular mechanisms of hepaticellular carcinoma. Arch. Toxicol.; 12-0931-932

. DM. Parkin. (2001) Global cancer statistics in the year 2000, Lancet Oncol; 2:533

. M. Maluccio and Covey A (2012) Recent Progress in Understanding, Diagnosis and Treating Hepatocellular Carcinoma . Cancer J. Clin. ; 1-6

. GLOBOCAN (2008) International Agency for Research on Cancer (IARC) Available at http://globocan.iarc.fr/

. EM. Lehman, AS. Soliman, KHA. Ismail, IA. Seifeldin, M. Ramadan, H. El-Hamzawy, CS. Shoustari, ML. Wilson (2008) Patterns of hepatocellular carcinoma incidence in Egypt from a population-based cancer registry Hepatology Research; 38 (5):465

. WA. Anwar, HM. Khaled, HA. Amra, H. El-Nezami, CA. Loffredo (2008) Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention. Mutat Res 2008;659:176-184

. M. Azab, S. Zaki, A. El-Shetey, M. Abdel-Moty, N. Alnoomani, A. Gomaa, S. Abdel-fatah, S. Mohiy, F. Atia (2011) Radiofrecquency ablation combined with percutanous ethanol injection in patients with HCC. Arab Journal of Gastroentrology; 12: 113-118

. EM. Lehman, and ML. Wilson (2009): Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: a systematic review and meta-analysis. Int. J. Cancer; 124 (3):690-7.

. W. Lau, and ECH. Lai (2008): Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreatic Diseases International 7(3):237-57.

. Egyptian Ministry of Health (2007) Egyptian Ministry of Health Annual Report: 2007 Available at http://www.mohp.gov.eg/Main.asp

. SC. Yates, M. Hafez, M. Beld, VV. Lukashov, Z. Hassan, G. Carboni, H. Khaled, M. McMorrow, M. Attia, J. Goudsmit (1999) Hepatocellular carcinoma in Egyptians with and without a history of hepatitis B virus infection: association with hepatitis C virus (HCV) infection but not with HCV RNA level. Am J Trop Med Hyg; 60(4): 714

. M. Abdel-Wahab, N. El-Ghawalby, M. Mostafa, S. Zakaria, M. Kamel, M. Abdel Khalid, M. Mabrouk (2007) Epidemiology of hepatocellular carcinoma in Egypt Mansoura Gastrpenterology center . Hepatogastroenterology; 54 (73): 157- 162

. A. Abou-El Hawa (2004) Early diagnosis of HCC and its differentiation from other hepatic space occupying lesions. MSc. Thesis, Tropical Medicine, Cairo University

. MM. Hassan, AS. Zaghloul, HB. El-Serag. O. Soliman, YZ. Patt, CL. Chappell, RP. Beasley, LY. Hwang (2001) The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J Clin Gastroenterol; 33: 123

. El-Zayadi A, Badran H, Barakat E. (2005) Hepatocellular carcinoma in Egypt: A single center study over a decade. World J. Gastroenterol.; 11(33): 5193 5198

. Bruix J, and Sherman M (2011) AASLD practice guidelines Management of Hepatocellular Carcinoma:An Update Hepatology; 53:3

. El-Serag HB, and Rudolph KL (2007) Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis. Gastroenterology; 132:2557

. H. Nordenstedt, DL. White, HB. El-Serag (2010) The changing pattern of epidemiology in hepatocellular carcinoma, Dig Liver Dis, 42, S206-14

. AF. Badawi, and MS. Michael (1999) Risk factors for hepatocellular carcinoma in Egypt: the role of HBV infection and schistosomiasis. Anticancer Res, 19(5c):4565-9

. F. Stickel, D. Schuppan, EG. Hahn, HK. Seitz (2002) Cocarcinogenic effects of alcohol in hepatocarcinogensis. Gut; 51:132-139

. A. Zekri, Z. Hassan, A. Bahnassy, GM. Sherif, D. Eldahshan, M. Abouelhoda, A. Ali, MM. Afez (2012) Molecular prognostic profile of Egyptian HCC cases infected with Hepatitis C virus. Asian Pacific Journal of cancer prevention; 13 (11): 5433

. JW. Sturm, and M. Keese. (2004) Multimodal treatment of hepatocellular carcinoma (HCC), Oncologie; 27:294-303

. AS. Lok, RK. Sterling, JE. Everhart. EC. Wright, JC. Hoefs, AM. DiBisceglie, TR. Morgan, H. YoungKim, WM. Lee, HL. Bonkovsky, JL. Dienstag, HALT-C Trial Group (2010) Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology; 138(2):493

. A. Teufel, A. Weinmann, C. Centner, A. Piendl, AW. Lohse, PR. Galle, S. Kanzler (2009) Hepatocellular carcinoma in patients with autoimmune hepatitis, World J Gastroenterol;15(5):578

. G. Esmat, T. Elbaz, M. El Akassas. (2013) Hepatocellular Carcinoma in Egypt: an update status. WDHD May 29, 2013

. A. Aguayo, and YZ. Patt (2001) Liver cancer. In Norman Gitlin (ed): Clinics in liver disease (Vol 5), published by Elsevier; Chapter 76; 476-512

. H. El-Serag (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroentrology 142(6):1264-1273

. BC. Song, YH. Chung, JA. Kim, WB. Choi, DD. Suh, SI. Pyo, JW. Shin, HC. Lee, YS. Lee, DJ. Suh (2002) Transforming growth factor

. CM. Sturgeon, MJ. Duffy, UH. Stenman, H. Lija, N. Brunner, DW. Chan, R. Babaian, RC. Bast, B. Dowell, FJ. Esteya, C. Haglund, LH. Harbeck, R. Molina, HJ. Nielsen, H. Rittenhouse, A. Semjonow, lM. Shih, P. Sibley, G. Soletormos, C. Stepan, L. Sokoll, BR. Hoffman, EP. Diamandis, National Academy of Clinical Biochemistry (2008) National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem;54(12): e11-e79

Downloads

Published

2017-04-26

How to Cite

A. El Sherbiny, N., Zaky, S., A. Gomma, A., A. Hassan, E., & A. Atta, N. (2017). Epidemiology of Hepatocellular Carcinoma in Fayoum Governorate-EgyptEpidemiology of Hepatocellular Carcinoma in Fayoum Governorate-Egypt. International Journal of Sciences: Basic and Applied Research (IJSBAR), 33(1), 21–32. Retrieved from https://www.gssrr.org/index.php/JournalOfBasicAndApplied/article/view/7192

Issue

Vol. 33 No. 1 (2017)

Section

Articles

License

Authors who submit papers with this journal agree to the following terms.